title: Nanotechnology applications in hematological malignancies (Review).
abstract: A major limitation to current cancer therapies is the development of therapy-related side-effects and dose limiting complications. Moreover, a better understanding of the biology of cancer cells and the mechanisms of resistance to therapy is rapidly developing. The translation of advanced knowledge and discoveries achieved at the molecular level must be supported by advanced diagnostic, therapeutic and delivery technologies to translate these discoveries into useful tools that are essential in achieving progress in the war against cancer. Nanotechnology can play an essential role in this aspect providing a transforming technology that can translate the basic and clinical findings into novel diagnostic, therapeutic and preventive tools useful in different types of cancer. Hematological malignancies represent a specific class of cancer, which attracts special attention in the applications of nanotechnology for cancer diagnosis and treatment. The aim of the present review is to elucidate the emerging applications of nanotechnology in cancer management and describe the potentials of nanotechnology in changing the key fundamental aspects of hematological malignancy diagnosis, treatment and follow-up.
authors.affiliation: Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Samir
authors.affiliation: Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
authors.forename: Basma M
authors.initials: BM
authors.lastname: Elgamal
authors.affiliation: Department of Clinical Pathology, Kasr Al‑Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
authors.forename: Hala
authors.initials: H
authors.lastname: Gabr
authors.affiliation: Department of Clinical Pathology, Kasr Al‑Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
authors.forename: Hatem E
authors.initials: HE
authors.lastname: Sabaawy
mesh_terms: D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D036103:Nanotechnology / Q000379:methods* / Q000639:trends